These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30443557)

  • 1. Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension.
    Bouzina H; Rådegran G
    ERJ Open Res; 2018 Oct; 4(4):. PubMed ID: 30443557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension.
    Bouzina H; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2021 Feb; 55(1):35-42. PubMed ID: 32597241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation.
    Säleby J; Bouzina H; Ahmed S; Lundgren J; Rådegran G
    ERJ Open Res; 2019 Oct; 5(4):. PubMed ID: 31754623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Bouzina H; Rådegran G
    ESC Heart Fail; 2021 Apr; 8(2):1230-1243. PubMed ID: 33403810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension.
    Bouzina H; Hesselstrand R; Rådegran G
    Pulm Circ; 2019; 9(4):2045894019895446. PubMed ID: 31908768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary, self-renewing erythroid progenitors develop through activation of both tyrosine kinase and steroid hormone receptors.
    Steinlein P; Wessely O; Meyer S; Deiner EM; Hayman MJ; Beug H
    Curr Biol; 1995 Feb; 5(2):191-204. PubMed ID: 7538024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification.
    Bouzina H; Rådegran G
    Pulm Circ; 2020; 10(3):2045894020931317. PubMed ID: 32595932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia.
    Zhang T; Kawaguchi N; Yoshihara K; Hayama E; Furutani Y; Kawaguchi K; Tanaka T; Nakanishi T
    Respir Res; 2019 Apr; 20(1):79. PubMed ID: 31023308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia.
    Croizat H; Nagel RL
    Am J Hematol; 1999 Feb; 60(2):105-15. PubMed ID: 9929101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Säleby J; Hesselstrand R; Rådegran G
    Pulm Circ; 2022 Jan; 12(1):e12041. PubMed ID: 35506077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right Atrial Function in Pulmonary Arterial Hypertension.
    Querejeta Roca G; Campbell P; Claggett B; Solomon SD; Shah AM
    Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003521; discussion e003521. PubMed ID: 26514759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of plasma transforming growth factor-β1 in idiopathic and heritable pulmonary arterial hypertension.
    Yan Y; Wang XJ; Li SQ; Yang SH; Lv ZC; Wang LT; He YY; Jiang X; Wang Y; Jing ZC
    Int J Cardiol; 2016 Nov; 222():368-374. PubMed ID: 27500766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Antibodies against Activin A and TGF-β Reduce Self-Supported, but Not Soluble Factors-Induced Growth of Human Pulmonary Arterial Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension.
    Kudryashova TV; Shen Y; Pena A; Cronin E; Okorie E; Goncharov DA; Goncharova EA
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between stem cell factor/c-kit expression in peripheral blood and blood pressure.
    Zhong HL; Lu XZ; Chen XM; Yang XH; Zhang HF; Zhou L; Wang L; Cao KJ; Huang J
    J Hum Hypertens; 2010 Mar; 24(3):220-5. PubMed ID: 19675587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracheal Smooth Muscle Cells Stimulated by Stem Cell Factor-c-Kit Coordinate the Production of Transforming Growth Factor-β1 and Fibroblast Growth Factor-2 Mediated by Chemokine (C-C Motif) Ligand 3.
    Oliveira LC; Danilucci TM; Chaves-Neto AH; Campanelli AP; Silva TC; Oliveira SH
    J Interferon Cytokine Res; 2016 Jun; 36(6):401-11. PubMed ID: 27123814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
    Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.
    Dickinson MG; Kowalski PS; Bartelds B; Borgdorff MA; van der Feen D; Sietsma H; Molema G; Kamps JA; Berger RM
    Cardiovasc Res; 2014 Sep; 103(4):573-84. PubMed ID: 25028387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.